Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells.
about
Killing Me Softly: Connotations to Unfolded Protein Response and Oxidative Stress in Alzheimer's DiseaseMitochondrial dysfunction: different routes to Alzheimer's disease therapyInhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiolGinkgo biloba extract ameliorates oxidative phosphorylation performance and rescues abeta-induced failureConvergence of amyloid-beta and tau pathologies on mitochondria in vivo.Alzheimer's proteins, oxidative stress, and mitochondrial dysfunction interplay in a neuronal model of Alzheimer's disease.A mitochondrial etiology of Alzheimer and Parkinson diseaseAstrocyte senescence as a component of Alzheimer's disease.Amyloid-Beta interaction with mitochondriaMitochondria, Amyloid β, and Alzheimer's DiseaseThe Broad Impact of TOM40 on Neurodegenerative Diseases in AgingConstitutive cAMP response element binding protein (CREB) activation by Alzheimer's disease presenilin-driven inositol trisphosphate receptor (InsP3R) Ca2+ signaling.Centella asiatica Attenuates Amyloid-β-Induced Oxidative Stress and Mitochondrial DysfunctionMitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicityThe mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease.Metabolic Characterization of Intact Cells Reveals Intracellular Amyloid Beta but Not Its Precursor Protein to Reduce Mitochondrial Respiration.Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau proteinBeneficial effects of novel antagonists of GHRH in different models of Alzheimer's diseaseAlterations in mitochondrial number and function in Alzheimer's disease fibroblastsNovel antioxidants protect mitochondria from the effects of oligomeric amyloid beta and contribute to the maintenance of epigenome function.No consistent bioenergetic defects in presynaptic nerve terminals isolated from mouse models of Alzheimer's diseaseSTX, a Novel Membrane Estrogen Receptor Ligand, Protects Against Amyloid-β Toxicity.Enhanced Neuroplasticity by the Metabolic Enhancer Piracetam Associated with Improved Mitochondrial Dynamics and Altered Permeability Transition Pore Function.Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice.Decreased NAA in gray matter is correlated with decreased availability of acetate in white matter in postmortem multiple sclerosis cortex.Melatonin and abeta, macular degeneration and alzheimers disease: same disease, different outcomes?Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesisNeurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue.Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes.Mitochondrial biogenesis and dynamics in neurodegeneration: a causative relationship.Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease.Senescent cells: SASPected drivers of age-related pathologies.The Essential Role of Soluble Aβ Oligomers in Alzheimer's Disease.Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease.Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration.A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam.Amyloid precursor protein processing and bioenergetics.Loss of mitofusin 2 links beta-amyloid-mediated mitochondrial fragmentation and Cdk5-induced oxidative stress in neuron cells.FLZ inhibited γ-secretase selectively and decreased Aβ mitochondrial production in APP-SH-SY5Y cells.Nuclear but not mitochondrial-encoded oxidative phosphorylation genes are altered in aging, mild cognitive impairment, and Alzheimer's disease.
P2860
Q26765824-61F89449-8D73-4CE6-A0ED-E5E4B03B9A70Q27009475-89DF29AF-6EF2-4DB2-B75A-C2A59F9DA381Q28478362-AD83BD8A-ECB3-48EA-BC1A-582459A5D7A5Q33680041-A3D93FCF-A12E-4000-AF42-F1F09C286232Q33876147-18D76EFC-9050-4F93-BF18-9E7E00FDDEACQ34127614-6F60CE2E-5C87-4A10-9FF7-870D598BB2BDQ34211127-705D5184-0017-439E-9D2C-901934F8FC6AQ34416365-7525CA74-394E-4979-9AB2-3BE977EEB20AQ34725635-6EE3FA91-542F-4603-9469-39411400EF69Q34922777-31F8BCF3-E610-4E6F-9CEB-81920E324750Q35137172-56433D9A-632E-469A-ADC5-412E1EBAA867Q35164866-37900FAF-6697-4AB4-B959-B94B2924E531Q35545533-0BCEEC9A-AF5C-4526-8E65-6BAA3D30A5D9Q35579318-79C0A060-4A65-4E86-99EB-073B51EC48F7Q35908404-13AE2D32-F738-49AE-AE7F-394E56BBC01FQ36231595-6EEC3B27-C111-45AC-8BE6-90F597DA9321Q36426980-DC0D6CEF-1308-4A0C-B0C2-43677F99B5AEQ36576387-57EEBFD3-6AB1-45FD-9019-F4BF87AF824FQ36709696-CD05DEEB-7AE4-4DA2-874C-3280A7CF31A7Q36818189-C7EB5247-07BC-4D36-932B-60F82C0963DEQ37078497-A0A27AD5-065E-4245-8EB3-144B8C63C996Q37127229-A1EAAE2F-1AA7-42F8-B32B-4A1F10FAA2E2Q37323658-B08A9C08-6FAF-42BD-811D-E62AE595BB09Q37414108-DCEC3326-8097-4405-84BA-B4CA7E06969DQ37432950-43818B8D-F0F6-4352-9626-1F5DB64CDC08Q37612356-DF24F45F-05DB-48C6-89B3-EEA5C1B6EF72Q37690524-C3AF7CED-0B22-47DF-A9E7-3045C01C21D1Q37954003-B03A98C9-8C63-470D-A722-D17D2D21BD92Q38028375-D0A0898B-7621-4405-9D6D-51BD2D1F3CFBQ38080468-3023640C-7586-417F-BD89-6EA5B258F151Q38217857-43C847E5-F177-45BD-B7B5-3C75764C76B6Q38248803-134F8343-0BD9-4996-B514-F37FC4E25DDDQ38400601-72B2059F-0B4C-4DA8-AFD5-C3D80EC68BC6Q38607493-43F7E08B-E589-473E-BDF4-6B325F8E1BC4Q38684594-804DFB03-B51A-423A-9529-EC7BA5D8AA4EQ38814123-406A49A8-9757-450D-A116-AB09F9DEC909Q38933148-CD6D74DB-FE3A-4B8E-9C2A-9F6109AA3475Q38943638-6D89918F-BA9B-4075-A6FB-A41B4C001716Q39090889-AB770B6A-8CF1-45A5-BAAC-8B27760B6CC7Q39236946-D7F69DC5-4872-452B-B9BB-7E071C2EA4E9
P2860
Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Amyloid-beta leads to impaired ...... in human neuroblastoma cells.
@en
Amyloid-beta leads to impaired ...... in human neuroblastoma cells.
@nl
type
label
Amyloid-beta leads to impaired ...... in human neuroblastoma cells.
@en
Amyloid-beta leads to impaired ...... in human neuroblastoma cells.
@nl
prefLabel
Amyloid-beta leads to impaired ...... in human neuroblastoma cells.
@en
Amyloid-beta leads to impaired ...... in human neuroblastoma cells.
@nl
P2093
P1476
Amyloid-beta leads to impaired ...... in human neuroblastoma cells.
@en
P2093
P2888
P304
P356
10.1007/S10571-009-9398-Y
P50
P577
2009-04-07T00:00:00Z